Objective: Sphenopalatine ganglion (SPG) block is used for a variety of craniofacial pain syndromes either through the transnasal route or via the infrazygomatic approach. Intraoperative imaging can identify the pterygopalatine fossa (PPF) but not the exact position of the SPG. Accurate localization of the SPG requires knowledge of the relevant anatomical landmarks.
INTRODUCTION
The sphenopalatine ganglion (SPG) is a parasympathetic ganglion in the course of greater petrosal nerve and is located in the pterygopalatine fossa (PPF). This ganglion has multiple connections to trigeminal, facial and sympathetic systems, consists of somatosensory, sympathetic as well as parasympathetic fibers and receives a sensory, parasympathetic and a sympathetic root. [1] [2] [3] [4] Sphenopalatine ganglion block is an accepted and effective method for treatment of variety of clinical conditions, such as cluster headaches, acute migraine, trigeminal and other facial neuralgias, pain relief in head and neck malignancies as well as amelioration of musculoskeletal pain. 1,2,4-9 The SPG blockade has been achieved with variety of methods. Commonly, the SPG is targeted by needle or electrode placement via the transnasal route through the sphenopalatine foramen (SPF) or percutaneously by an infrazygomatic approach. [10] [11] [12] [13] [14] Pterygopalatine fossa (PPF) anatomy has been described by many authors 13,15-17 but we could not come across any study giving detailed morphometric parameters to locate the SPG via different approaches. For the therapy to be effective and safe, accurate localization of the SPG is mandatory. Thus, the present study was designed to identify anatomical landmarks which would help the clinicians in accurate targeting of the SPG. This would also help in avoiding complications related to incorrect placement of needles.
MATERIALS AND METHODS
The study was conducted on 30 mid sagittal sections of the head and neck. These cadaveric specimens were from adult North West Indian population, available in the Department of Anatomy, PGIMER. Transnasal and per cutaneous infrazygomatic approaches were used to localize the JDQJOLRQ 7KH VSHFLPHQV ZHUH ¿[HG LQ DQDWRPLFDO SRVLWLRQ to take various measurements. The metrical parameters were taken with the help of a digital vernier caliper accurate up to 0.02 mm. This study has been approved by the institute ethical committee.
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RESULTS

Intranasal Approach to the Pterygopalatine Ganglion
1. Position of the SPF in the nasal cavity: the SPF was located at an average distance of 55 mm from the anterior nasal spine. In most of the specimens, this value was between 50 and 60 mm. The mean value of the angle of the line joining the anterior nasal spine and the foramen, with the hard palate was found to be 22 mm. In about 70% of cadavers, this angle was 20º. The relative position of the SPF in relation to its distance from the hard palate as well as from the base of the skull was analyzed. The measurements show that the foramen was located at or just superior to the midpoint of the distance between the hard palate and the base of the skull in most of the cases (Table 1 ).
Position of the SPG in relation to the SPF (Table 2):
The mean of the shortest distance from the center of the foramen to the nearest point of the SPG was found to be 6.3 mm. In three-dimensional positioning, the SPG was on an average 4 mm posterior and 4.7 mm lateral to the SPF. If one passes an endoscope through the foramen to the ganglion, the endoscope would subserve an angle of 48.3° with the coronal plane and 51.7° with the sagittal plane. In practical terms, a line joining the center of the foramen to the ganglion was inclined about 50° in both the sagittal and the coronal planes.
Localization of the SPG via the Infrazygomatic Approach (Table 3)
The distance of the PMF from the skin surface from the entry point of the needle ranged roughly between 4 and 5.5 cm (mean 4.5 cm ) while the SPG was located at a depth of 4.5 to 6.3 cm (mean 5.3 cm). The angle of the needle when it touched the ganglion was 7° with the coronal plane (inferiorly) and 7° with the transverse plane (posteriorly). These two angles were remarkable in being almost same for all specimens in both the measured planes.
DISCUSSION
Sphenopalatine ganglion is commonly targeted either through the transnasal approach or via the percutaneous infrazygomatic technique. The transnasal injection technique, either blindly or with the assistance of a speculum, carries the danger of nasal mucosa sloughing during needle insertion. 12 This led to the development of the transnasal endoscopic technique in which the topical block, or QHHGOH LQ¿OWUDWLRQ ZDV SHUIRUPHG XQGHU GLUHFW YLVLRQ XVLQJ rigid sinuscope. 10, 13 It is well documented that drug delivery directly in the vicinity of the SPG is more effective and accurate in pain relief than instillation of the drug in the middle meatus 12, 14, 18 In the transnasal endoscopic approach, the SPF is visualized behind the middle turbinate and a needle is inserted through this foramen into the PPF for injection of anesthetic drugs for SPG block. 4 The infrazygomatic approach is necessary to perform the majority of neurolysis techniques. The infrazygomatic approach has been commonly performed blindly in the past. In this technique, the needle is inserted under the zygomatic arch and advanced through the PMF to reach the PPF which houses the SPG. In recent years, the approach is carried out by using image guidance and a direct lateral approach to place a canula into the superior portion of the PPF without requiring local anesthetic to diffuse across mucous and bony membranes and does not rely on secondary spread via the nerves of the greater palatine canal. Our results show that the SPF was consistently located either midway or 2 to 3 mm superior to the midpoint of a line MRLQLQJ WKH KDUG SDODWH DQG WKH ÀRRU RI WKH DQWHULRU IRVVD MXVW behind the posterior attached end of the middle turbinate. It was also observed that a needle passing though the SPF would have to be inclined at an angle of about 50º in both coronal and sagittal planes to reach the SPG. Passing through the SPF at this angle, the SPG was found to be located at a mean distance of 6.3 mm and about 4 to 5 mm posterior and 4 to 5 mm lateral to the SPF.
Anatomical measurements for the infrazygomatic technique demonstrated that a needle passed through the skin below the zygomatic bone at the junction of its body and arch should be inclined 7º posteriorly and 7º inferiorly and advanced to a depth of 4.5 to 6.3 cm to reach the SPG. The direction of the needle was found to be remarkable consistent in most of the specimens.
7KH 33) KDV EUDQFKHV RI WKH PD[LOODU\ DUWHU\ DQG in addition to the various nerves in relation to the SPG. Injury to the vessels can cause postoperative hematoma formation while numbness and hypoesthesia of the soft palate have been described due to injury to the greater palatine nerve. 16 There is adequate literature available of the detailed anatomy of the SPG as well as the PPF. However, morphometric data regarding localization of the SPG within the PPF via the commonly used routes is not available. The GDWD REWDLQHG IURP WKLV FDGDYHULF VWXG\ GH¿QH ODQGPDUNV that provide safe entrance into PPF via transnasal and ll metrical measurements are in millimeter percutaneous infrazygomatic approaches. It is hoped that the measurements and parameters detailed in this study would help the clinician in precise lesion making or targeting and thus minimize the incidence of complications.
